Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPALA trial
2019-003003-35Phase 2Active
- Sponsor
- CHU de Lille
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in pleural mesothelioma, sponsored by CHU de Lille. Started Mar 2020; status: active.
02
Drugs
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2019-003003-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003003-35.